Promoting freedom, innovation, and growth

Connect with IPI

Receive news, research, and updates

Are Politics Driving the CDC's Pending Decision on an Infant Meningitis Vaccine?

  Recap PDF 

For decades, the Centers for Disease Control and Prevention has championed immunization against a host of deadly diseases. But, now, in a sudden reversal, CDC is signaling it may not recommend the routine administration of a proven new vaccine to prevent infant meningitis, an often fatal disease.

This briefing will feature the release of a new study evaluating the disparities in how government programs place economic value on human life, as well as testimonies from health care and FDA experts.

Please join us as we examine how and why the CDC may be restricting access to a new meningitis vaccine for infants, and the impact this may have on patient care.

Special Remarks By

The Honorable Michael C. Burgess, M.D.
US House of Representatives (TX-26)

Panelists:

Christopher Stomberg, Ph.D., Partner, Bates White Economic Consulting
Gretchen Moen, RN, MS, CPNP-Pediatric Nurse Practitioner, Eagan Child and Family Care
Richard G. Judelsohn, MD, FAAP-Medical Director, Erie County Department of Health
Peter Pitts, President & Co-Founder, Center for Medicine in the Public Interest
Moderated by Merrill Matthews, Ph.D., Institute for Policy Innovation
Q & A following the presentations

Event Details:

Friday, October 14, 2011
10:00 am to 11:30 am
Rayburn 2325, Rayburn House Office Building
Capitol Hill, Washington DC

 

  • TaxBytes-New

Copyright Institute for Policy Innovation 2017. All Rights Reserved Privacy Policy Contact IPI.

e-resources e-resources